Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters…
Obesity pills from Eli Lilly, Novo Nordisk near US launch
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both companies expect to launch oral obesity drugs in the U.S.…








Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150…